Coherus Oncology (CHRS) Prepaid Assets (2013 - 2026)

Coherus Oncology has disclosed Prepaid Assets across 14 years of filings, most recently posting $5.4 million for Q2 2026.

• In Q2 2026, Prepaid Assets fell 54.3% year-over-year to $5.4 million; the TTM figure through Jun 2026 stood at $5.4 million (down 54.3% YoY), while the FY2025 annual figure was $6.8 million, down 33.48% from the prior year.
• Prepaid Assets came in at $5.4 million for Q2 2026 at Coherus Oncology, down from $9.4 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $23.7 million in Q4 2023 to a low of $5.4 million in Q2 2026.
• Average Prepaid Assets over 5 years is $15.0 million, with a median of $15.1 million recorded in 2024.
• Year-over-year, Prepaid Assets surged 67.28% in 2022 and sank 56.87% in 2024.
• Over 5 years, Prepaid Assets stood at $22.9 million in 2022, then increased by 3.41% to $23.7 million in 2023, then slumped by 56.87% to $10.2 million in 2024, then plunged by 33.48% to $6.8 million in 2025, then decreased by 21.26% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $5.4 million in Q2 2026, $9.4 million in Q1 2026, and $6.8 million in Q4 2025.